Novartis Pays Over $642 Million to Settle Allegations of Improper Payments to Patients and Physicians
Pharmaceutical company Novartis Pharmaceuticals Corporation (Novartis), based in East Hanover, New Jersey, has agreed to pay over $642 million in separate settlements resolving claims that it violated the False Claims Act (FCA).
- Date:July 1, 2020
- Agency:Department of Justice
- Criminal and Civil Actions